Skip to main content
Knowledge we build together Honest and transparent Real people, real data

Insulin resistance: what you can discuss at the practice

Topic illustration: Insulin resistance: what you can discuss at the practice
Insulin resistance: what you can discuss at the practice

Anyone wanting to know whether their insulin sensitivity is improving will eventually need laboratory values. Most of them have long been on every routine report – they simply need reading together. One is almost always missing and can be requested. And one of the most important points has nothing to do with values at all, but with how the conversation is conducted.

Most of it is already there

The commonest misconception on this topic is the assumption that a whole series of exotic tests is needed. In fact a normal routine panel already contains four of the five building blocks required for an assessment of insulin resistance: fasting glucose, HbA1c, triglycerides and HDL cholesterol.

From two of them the TyG index can be calculated, from two others the ratio of triglycerides to HDL. Both count as usable approximations for insulin sensitivity, and both cost nothing extra – the numbers are already there.4

What is measured anyway – and what is notA contrast. Usually already present are fasting glucose, HbA1c, triglycerides, HDL cholesterol and liver values; from four of these the TyG index and the triglyceride to HDL ratio can be calculated with no extra draw. Fasting insulin, by contrast, has to be requested, as it is not part of every standard panel; with a documented indication the statutory insurer often covers it, otherwise it falls to the patient. What is measured anyway – and what is not Most building blocks already appear on any routine report. Only one is almost always missing. Usually already there• Fasting glucose• HbA1c• Triglycerides• HDL cholesterol• Liver values (ALT, GGT)From these four the TyG index andtriglyceride/HDL can be calculated –with no extra draw.Has to be requested• Fasting insulinIs not part of every standard panel.With a documented indication thestatutory insurer often covers it;otherwise it falls to the patient –the order of magnitude is in the lowdouble digits in euros.Without fasting insulin no HOMA-IR can be calculated. Everything else works without it.
Fig. 1: Four of five building blocks are usually already on the report.

So anyone digging out their last laboratory report already has a starting point. That is the simplest first step and costs nothing but a look through the paperwork.

The one value that is usually missing

Fasting insulin is not part of every standard panel. Yet it is the only value that answers the actual question directly: how much insulin does the body need for its current blood sugar? Without it, no HOMA-IR can be calculated either.

On the question of cost, in general terms: with a documented indication – such as metabolic syndrome, fatty liver or PCOS – statutory insurers often cover the measurement. Whether that applies in an individual case is decided by the practice, and handling differs. As a self-funded test, an insulin measurement sits in a manageable range.

💡 The small trick with timing

If a routine blood draw is due anyway, fasting insulin can often be included without an extra appointment and without a second needle. It is worth asking before the draw rather than after – afterwards a fresh sample is needed.

The most important limitation that hardly anyone mentions

Here comes a point that popular accounts almost always omit and that matters precisely for people with established type 2 diabetes: HOMA-IR can come out falsely normal in diabetes.

The reason lies in how it is calculated. HOMA-IR assumes that the pancreas answers insulin resistance with more insulin. If beta-cell function is already impaired, that answer is weaker – insulin in the blood is lower, and the calculated index looks better than the situation actually is.2

In practice this means: an unremarkable HOMA-IR in established diabetes is no reason for reassurance. And a falling HOMA-IR over time can mean two completely different things – better insulin sensitivity, or declining insulin production. Telling those two apart is precisely the task that requires a medical assessment.

What HOMA-IR is not

It is not a diagnostic criterion. The recognised criteria for prediabetes and diabetes are HbA1c, fasting plasma glucose and the oral glucose tolerance test.5 HOMA-IR adds to that picture; it does not replace it.

For orientation, laboratories typically give: up to about 1 unremarkable, 1 to 2 a grey zone, above 2 a sign of insulin resistance or fatty liver, above 2.5 insulin resistance being very likely.3 These boundaries are orientation, not diagnosis – studies work with different thresholds, and insulin measurement is less standardised between laboratories than glucose or HbA1c.

🔬 Why the same laboratory matters more than the exact threshold

Different laboratories use different insulin assays that are not identically calibrated. Two measurements from two institutions are therefore harder to compare than two from the same one. For tracking a course, continuity of laboratory matters more than whether a value sits at 2.4 or 2.6.

Four questions that open the conversation

The trickiest part is not technical but interpersonal. Anyone arriving at the practice with a printed list from the internet and demanding investigations rarely gets the best conversation. Anyone bringing a concrete question usually does.

Four questions for the conversationFour questions for the medical conversation. First: could fasting insulin be included next time. Second: would HOMA-IR be meaningful or rather not, since with established diabetes it can come out falsely normal. Third: could we repeat the same panel in a few months, since tracking a course beats any single measurement. Fourth: what would tell you that something has improved. Four questions for the conversation Questions rather than demands – the decision about testing rests with the practice. 1„Could fasting insulin be includednext time?“Concrete, small and answerable.Better than a list of ten values.2„Would HOMA-IR be meaningfulin my case – or rather not?“With established diabetes it can comeout falsely normal. The practice knowsthat better than any website.3„Could we repeat the same panelin a few months?“Tracking a course beats any singlemeasurement. And it costs less thana second appointment.4„What would tell you thatsomething has improved?“Perhaps the most important question.It moves interpretation to whereit belongs.Coming with a question rather than a demand generally produces the better conversation.
Fig. 2: Four formulations that stay questions rather than becoming demands.

I consider the fourth question the most important: what would tell you that something has improved? It reverses the direction of view. Instead of collecting and interpreting values yourself, you ask for the criterion – and get something that applies to your own case rather than to a study average.

What else is worth asking about

Besides blood values there are two investigations often relevant to insulin resistance that can be raised.

  • Keep an eye on liver values. ALT and GGT are usually on the report anyway. Raised values can indicate a fatty liver – and that plays a central role in insulin resistance.
  • An ultrasound of the liver. It shows fatty change that blood values do not always reveal. Not routine for everyone, but an obvious step where there is a corresponding suspicion.
  • Waist circumference. Costs nothing, takes a minute and says more about visceral fat than body weight does. It can be tracked at home.
  • Blood pressure over time. It belongs to the same picture and often changes in parallel with insulin sensitivity.

How to validate results later

For tracking a course the same holds as for any measurement: comparability beats precision. Four points make the difference between a series of numbers and a conclusion.

Point Why
Same laboratory insulin assays are not identically calibrated between institutions
Matching conditions morning, fasted, at least eight hours without food
Gap from the last training session the acute effect lasts 24 to 48 hours and distorts the comparison
Intervals of three to six months shorter intervals mostly show day-to-day variation
Always the same panel otherwise the derived indices cannot be calculated consistently

And one point that follows from the physiology: measuring too early means measuring too early. The liver responds within days, the pancreas needs weeks to months.6 A check after four weeks can therefore disappoint although everything is on track.

Why the timing of the draw matters

Fasting insulin varies more than most other laboratory values. It responds to the evening before, to sleep, to stress – and to exercise. Anyone who trained hard the previous day measures a value shaped by the acute training effect rather than by the baseline.

That is no reason to skip training, but a reason to place the draw deliberately. A two-day gap from the last intense session makes two measurements considerably more comparable. Anyone training regularly does best to choose the same weekday with the same gap every time – then at least the training effect stays constant.

The same holds for the evening before. A fatty late meal reaches into the morning. For tracking a course, a normal, unremarkable evening is a better starting point than a particularly disciplined one – because what should be captured is everyday life, not a special case.

What belongs in the record so it is still useful later

A practical note that often becomes apparent only when it is too late: reports accumulate, and after two years nobody remembers the circumstances under which a value arose.

It pays to note three things with every report – date, laboratory and the circumstances. Such as: how long fasted? When was the last training session? Were there particulars such as illness, heat or a short night? Those three lines later decide whether a comparison is possible at all.

Anyone working digitally does best to keep a small table: date, fasting glucose, fasting insulin, triglycerides, HDL, HbA1c – and the calculated values alongside. Then the direction is visible at a glance instead of hunting through old letters each time.

What to expect realistically

Not every practice will want to measure fasting insulin, and there are substantive reasons for that. The value is not part of the diagnostic criteria, it is less standardised than glucose, and with established diabetes its informative value is limited. A refusal is therefore not obstruction but often a reasoned judgement.

If that is the case, plenty remains: the TyG index and triglyceride-to-HDL can be calculated from values measured anyway. Both serve for tracking a course, and both cost nothing extra. That is no substitute for HOMA-IR, but it is considerably more than nothing.

⚠️ One point that takes priority

Anyone taking glucose-lowering medication who markedly changes diet or exercise should discuss it beforehand – not because of the laboratory values, but because medication requirements can shift. On insulin or sulfonylureas, an unchanged dose alongside improved insulin sensitivity can lead to a hypo. That is the more important reason to talk than any laboratory value.

A word on self-test kits from the internet

There are now providers who post out blood tests for self-collection, some with fasting insulin in the package. That sounds convenient but has two catches worth knowing.

The first is technical: insulin is not particularly stable in blood. Little time should pass between collection and processing, and the sample should stay cool. Shipping over two days is not ideal for that, and providers handle it differently.

The second weighs more heavily: a laboratory value without interpretation is a number, not a finding. Anyone seeing a raised value on screen with nobody to place it in their own context mainly gains uncertainty. The same value via the practice may cost little more and comes with the thing that makes it useful in the first place.

The honest closing thought

Laboratory values are useful, but they are not progress itself. They are a snapshot, taken on one morning, with one particular method. What they can do: show a direction when followed over months under matching conditions. What they cannot do: answer whether you are on the right path – that needs somebody who knows the whole case.

The best way to handle it is unspectacular: dig out the last report, bring one concrete question, repeat the same thing in a few months. That is less exciting than a hunt for numbers, but it is what eventually turns into a reliable conclusion.

The essentials at a glance

  • Four of five building blocks are usually already on the routine report: fasting glucose, HbA1c, triglycerides and HDL.
  • From these, the TyG index and the triglyceride-to-HDL ratio can be calculated with no extra draw.
  • Fasting insulin is usually missing and has to be requested – with a documented indication insurers often cover it.
  • Important for people with diabetes: HOMA-IR can come out falsely normal when beta-cell function declines.
  • HOMA-IR is not a diagnostic criterion – those are HbA1c, fasting glucose and the glucose tolerance test.
  • For tracking a course, the same laboratory matters more than the exact threshold, because insulin assays are calibrated differently.
  • The most effective question in the conversation: „What would tell you that something has improved?“
  • Anyone on medication who changes things markedly should discuss it beforehand – because of hypo risk, not because of the values.

Sources

Sources as of: 12 Aug 2026.

  1. Matthews DR et al., the HOMA-IR formula: fasting glucose × fasting insulin, divided by 405 (mg/dl) or 22.5 (mmol/l). Common study thresholds for insulin resistance lie at about 2.0 to 2.5. ncbi.nlm.nih.gov/PMC4052181 (opens in a new window)
  2. Laboratory note on the limits of HOMA-IR: with established diabetes mellitus a falsely normal index can be calculated where beta-cell function is impaired. ganzimmun.de (opens in a new window)
  3. Laboratory reference for interpreting HOMA-IR: values up to 1 count as ideal, 1 to 2 as a grey zone, above 2 as a sign of insulin resistance or fatty liver, above 2.5 as insulin resistance being very likely. fennerlabor.de (opens in a new window)
  4. Comparison of surrogate markers (HOMA-IR, TyG index, triglyceride-to-HDL) in a Bayesian network analysis: HOMA-IR predicted diabetes best, the TG/HDL ratio dyslipidaemia, and the TyG index bridged both. PLOS One (2025). journals.plos.org (opens in a new window)
  5. American Diabetes Association: the recognised diagnostic criteria are HbA1c, fasting plasma glucose and the oral glucose tolerance test – not HOMA-IR. diabetes.org (opens in a new window)
  6. Lim EL et al.: Reversal of type 2 diabetes – normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 54(10):2506-2514 (2011). Liver fat and hepatic insulin sensitivity changed within seven days, beta-cell function over eight weeks. pubmed.ncbi.nlm.nih.gov/21656330 (opens in a new window)
Share

These are plain links — no tracking scripts are loaded.